Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Current Assets (2020 - 2025)

Intelligent Bio Solutions has reported Current Assets over the past 5 years, most recently at $8.5 million for Q2 2024.

  • For Q2 2024, Current Assets rose 120.95% year-over-year to $8.5 million; the TTM value through Jun 2024 reached $8.5 million, up 120.95%, while the annual FY2024 figure was $8.5 million, 120.95% up from the prior year.
  • Current Assets for Q2 2024 was $8.5 million at Intelligent Bio Solutions, down from $11.5 million in the prior quarter.
  • Over five years, Current Assets peaked at $20.0 million in Q4 2020 and troughed at $2.3 million in Q2 2020.
  • A 5-year average of $10.0 million and a median of $9.7 million in 2022 define the central range for Current Assets.
  • Biggest five-year swings in Current Assets: skyrocketed 678.1% in 2021 and later crashed 67.2% in 2023.
  • Year by year, Current Assets stood at $20.0 million in 2020, then decreased by 29.46% to $14.1 million in 2021, then crashed by 54.72% to $6.4 million in 2022, then crashed by 53.83% to $2.9 million in 2023, then surged by 189.82% to $8.5 million in 2024.
  • Business Quant data shows Current Assets for INBS at $8.5 million in Q2 2024, $11.5 million in Q1 2024, and $2.9 million in Q4 2023.